Prostate Cancer StatisticsThis National Cancer Institute video provides key facts and statistics on prostate cancer diagnosis and treatment. This National Cancer Institute video provides key facts and statistics on prostate cancer diagnosis and treatment. ...
Prostate Cancer Statistics - Key Facts." http://info.cancerresearchuk.org/cancerstats/types/prostate, 2009.Canadian Cancer Society. Prostate Cancer Statistics 2009. Ref Type: GenericProstate Cancer Statistics, Cancer Research, London, UK, 2011....
Genetic testing, to identify pathogenic or likely pathogenic variants in prostate cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform cancer prevention and early detection options for their immediate blood relati
As I am writing this case, one patient told me he had colon cancer and underwent surgery and chemotherapy. He had already spent about RM200,000 ( I am not sure if this figure is corrrect or not. I did not see his medical bills). Many years ago, I knew of a medical doctor who s...
Prostate cancer, Incidence, Mortality, Epidemiological distribution, China References [1] Bray F, Ferlay J, Soerjomataram I,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-...
Prostate cancer is the second most frequent cancer among men and the fifth leading cause of cancer-related death worldwide [1]. Management of advanced prostate cancer has dramatically evolved over the past 15 years. Treatments approved for metastatic castration-resistant prostate cancer (mCRPC) includ...
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. Article PubMed Google Scholar Tindall EA, Monare LR, Petersen DC, van Zyl S, Hardie R-A, Segone AM, et al. Clinical ...
Prostate cancer (PC) is the second most commonly diagnosed cancer among men worldwide, following lung cancer, and the first among men in the USA [1]. Although clinical outcomes are excellent for patients with localized disease, patients with metastatic prostate cancer (mPC) have poor prognosis,...
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. ...
The randomized phase 3 CHART trial (NCT03520478) revealed that rezvilutamide (REZ) plus androgen deprivation therapy (ADT) in high-volume, metastatic, hormone-sensitive prostate cancer (mHSPC) significantly enhanced radiographic progression-free and overall survival than bicalutamide (BIC)-ADT. Accordin...